Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection
about
Enzymatic modifications of exopolysaccharides enhance bacterial persistenceUrinary tract infections: epidemiology, mechanisms of infection and treatment optionsGram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary TractPathogenesis of Streptococcus urinary tract infection depends on bacterial strain and β-hemolysin/cytolysin that mediates cytotoxicity, cytokine synthesis, inflammation and virulenceImpact of host age and parity on susceptibility to severe urinary tract infection in a murine model.Prognostic value of semi-quantitative bacteruria counts in the diagnosis of group B streptococcus urinary tract infection: a 4-year retrospective study in adult patientsβ-Hemolysin/cytolysin of Group B Streptococcus enhances host inflammation but is dispensable for establishment of urinary tract infection.Human bladder uroepithelial cells synergize with monocytes to promote IL-10 synthesis and other cytokine responses to uropathogenic Escherichia coli.Preventive effect of Lactobacillus reuteri CRL1324 on Group B Streptococcus vaginal colonization in an experimental mouse model.Leukocyte inflammatory responses provoked by pneumococcal sialidase.Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.Increased Age, but Not Parity Predisposes to Higher Bacteriuria Burdens Due to Streptococcus Urinary Tract Infection and Influences Bladder Cytokine Responses, Which Develop Independent of Tissue Bacterial Loads.Group B streptococcus cystitis presenting in a diabetic patient with a massive abdominopelvic abscess: a case report.Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli.Molecular Characterization of Nonhemolytic and Nonpigmented Group B Streptococci Responsible for Human Invasive Infections.Identification of potential protein biomarkers for early detection of pregnancy in cow urine using 2D DIGE and label free quantitation.From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa.Host Sialic Acids: A Delicacy for the Pathogen with Discerning Taste.Discovery and characterization of de novo sialic acid biosynthesis in the phylum Fusobacterium.Enterococcus faecalis promotes innate immune suppression and polymicrobial catheter-associated urinary tract infection.Immunomodulation of Lactobacillus reuteri CRL1324 on Group B Streptococcus Vaginal Colonization in a Murine Experimental Model.Local drug delivery in the urinary tract: current challenges and opportunities.Pathogenesis of Proteus mirabilis Infection.Type 2 NADH Dehydrogenase Is the Only Point of Entry for Electrons into the Streptococcus agalactiae Respiratory Chain and Is a Potential Drug Target.
P2860
Q27009503-201D1C14-741E-48BC-BB35-9DECE9655A41Q27022487-73DC7CBD-0DE9-42F0-AA8B-86B2017D87AEQ28829569-EE866444-6DF8-4EEB-BBA9-7A928A32A009Q28972267-3FEAFAB0-4E83-473D-933E-7A30034F9D19Q33623814-F63155D0-021B-455A-AE08-CD875538EA1AQ34458308-05D79355-BFD2-4101-A875-C18B1FB4B937Q34626092-D0557C31-3DB9-4872-AEAB-B027E33DCFEEQ35025542-81D9B1E4-EB8F-476E-BC64-294E33FBF65FQ35580560-B15774FE-CBF0-4006-8221-C4065AE3183AQ35652328-18E8CFF3-0153-4C58-A3F8-BE1262212CE8Q36163174-22FFED20-764F-4754-AACE-05D0949FEFD4Q36218442-8527EC5C-D4AC-4B61-AA73-79CF7B4ED1CEQ36237790-5FC0BD0C-FA77-4EC3-BFA7-14BECA1717E9Q36396848-F5EBEC1B-D034-4259-8048-AA74B0056622Q36434355-D82E2FB7-2B88-4074-8044-E44DFC876C4FQ37097132-6C142439-9E16-4AFE-BCE2-78BC0F0D032AQ38142595-9F3D9A83-E07A-40D0-969B-68A2B17B8743Q38583064-7DB281E5-B7A0-44C3-9A15-C67335966136Q39404763-12A2EC51-B20D-46FE-B7B1-97DA8CE75923Q40052544-4F331684-40F7-415D-B76D-1CF19DC29E6CQ40918656-50D3C1AF-BDA6-46BC-9DF3-9896E1E0E155Q49685896-2B846442-442C-480B-9B29-E7674C4CABECQ50102491-8F6AD942-38FD-46F9-8252-0BC9DCE9054EQ55518525-4E55462B-EB13-40D2-86E7-561945DB5607
P2860
Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Immune activation and suppress ...... del of urinary tract infection
@ast
Immune activation and suppress ...... del of urinary tract infection
@en
type
label
Immune activation and suppress ...... del of urinary tract infection
@ast
Immune activation and suppress ...... del of urinary tract infection
@en
prefLabel
Immune activation and suppress ...... del of urinary tract infection
@ast
Immune activation and suppress ...... del of urinary tract infection
@en
P2860
P50
P356
P1476
Immune activation and suppress ...... del of urinary tract infection
@en
P2093
Drew J Schwartz
Warren G Lewis
P2860
P304
P356
10.1128/IAI.00122-11
P407
P577
2011-06-20T00:00:00Z